Shots: The Onyx ONE global study involves assessing of Resolute Onyx DES vs Biosensor International’s BioFreedom DCS in ~2000 high bleeding risk patients with one month of dual antiplatelet therapy […]readmore
Tags : High bleeding risk
Shots: Onyx ONE Clear study will assess one-month DAPT in high bleeding risk patients implanted with the Resolute Onyx DES in the US and Japan evaluating its safety i.e. risk […]readmore